Lv0
0 积分 2023-06-15 加入
Integrated ubiquitomics characterization of hepatocellular carcinomas
3个月前
已完结
Repurposing Resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression
3个月前
已完结
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab–bevacizumab
3个月前
已完结
Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy
3个月前
已完结
LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma
3个月前
已完结
皖公网安备34019202002308
